文献速递食管胃疾病与幽门螺杆菌消化道肿瘤与早癌消化内镜

幽门螺杆菌根除后发现的原发性胃肿瘤患者异时性胃癌的发生率

Incidence of metachronous gastric cancer in patients whose primary gastric neoplasms were discovered after Helicobacter pylori eradication.
PubMed 文献 · Gastrointest Endosc · 2019-02-27

该研究分析在初次治愈性内镜黏膜下剥离术(ESD)前超过1年(根除组,180例)或后(对照组,602例)成功根除幽门螺杆菌的连续患者的前瞻性数据,随访超过2年。倾向评分匹配174对后,异时性胃癌(MGC)发生率两组相似(每1000人年33.9 vs 对照组40.8,P = .454),中位随访4.1年(四分位距3.0-5.6)。结论认为初次治愈性ESD后的随访监测频率应保持不变,无论幽门螺杆菌根除是在初次治愈性ESD之前还是之后进行。

要点

  • 倾向匹配174对后,根除组MGC发生率为每1000人年33.9,对照组为每1000人年40.8(P = .454)。
  • 中位随访4.1年(四分位距3.0-5.6),IPTW分析及排除123例根除后不足5年者后两组发生率仍相似。
  • 多因素Cox回归显示年龄、分化型组织学及初始多发性是初次治愈性ESD后MGC的预测因素。

核心结论

  • 初次治愈性ESD后的随访监测频率应保持不变,无论幽门螺杆菌根除是在初次治愈性ESD之前还是之后进行。

研究设计与样本

  • 分析前瞻性收集的连续患者数据,患者为初次治愈性ESD前超过1年(根除组,180例)或后(对照组,602例)成功根除幽门螺杆菌者,且均接受内镜随访超过2年;采用倾向评分匹配和逆概率治疗加权(IPTW)调整混杂因素。

主要发现

  • 倾向匹配174对后,MGC发生率两组相似(根除组每1000人年33.9 vs 对照组每1000人年40.8,P = .454),中位随访4.1年(四分位距3.0-5.6)。
  • 使用IPTW分析时两组发生率也相似,即使在排除123例初次ESD前成功根除幽门螺杆菌不足5年的患者后仍相似。
  • 多因素Cox回归分析显示年龄、分化型组织学及初始多发性是初次治愈性ESD后患者MGC的预测因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The incidence of metachronous gastric cancer (MGC) in patients whose primary gastric neoplasm is discovered after Helicobacter pylori eradication remains unclear. Here, we evaluated the long-term effect of previous H pylori eradication on development of MGC after endoscopic submucosal dissection (ESD). METHODS: We analyzed prospectively collected data of consecutive patients with successful H pylori eradication more than 1 year before (eradicated group, 180 patients) or after (control group, 602 patients) initial curative ESD. These patients were also followed by endoscopy for over 2 years. Propensity score matching and inverse probability of treatment weighting (IPTW) were used to adjust for confounding variables during data analysis. The main outcome was the incidence of MGC after initial ESD. RESULTS: In a propensity-matched analysis of 174 pairs, the incidence of MGC was similar in the 2 cohorts (33.9 per 1000 person-years vs 40.8 per 1000 person-years in the control group, P = .454) at a median follow-up of 4.1 years (interquartile range, 3.0-5.6). Incidences were also similar in the 2 groups when data were analyzed using IPTW, even after exclusion of 123 patients with successful H pylori eradication <5 years before initial ESD. Multiple Cox regression analysis revealed age, differentiated-type histology, and initial multiplicity were predictors of MGC in patients after initial curative ESD. CONCLUSIONS: The frequency of follow-up surveillance after initial curative ESD should be kept constant, irrespective of whether H pylori eradication is performed before or after initial curative ESD.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Okada K, Suzuki S, Naito S, et al. Incidence of metachronous gastric cancer in patients whose primary gastric neoplasms were discovered after Helicobacter pylori eradication. Gastrointest Endosc. 2019. PMID: 30825537. doi:10.1016/j.gie.2019.02.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。